A randomized, open-label, multiple dosing, crossover study to evaluate the pharmacokinetic drug-drug interaction and safety between nebivolol and rosuvastatin in healthy male volunteers

Trial Profile

A randomized, open-label, multiple dosing, crossover study to evaluate the pharmacokinetic drug-drug interaction and safety between nebivolol and rosuvastatin in healthy male volunteers

Completed
Phase of Trial: Phase I

Latest Information Update: 03 May 2017

At a glance

  • Drugs Nebivolol (Primary) ; Rosuvastatin (Primary)
  • Indications Hyperlipidaemia; Hypertension
  • Focus Therapeutic Use
  • Acronyms EL-1401-101
  • Sponsors Elyson Pharm
  • Most Recent Events

    • 16 Feb 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top